What was Global Pharmatech’s price range in the past 12 months?
Global Pharmatech lowest stock price was $0.05 and its highest was $0.08 in the past 12 months.
What is Global Pharmatech’s market cap?
Global Pharmatech’s market cap is $33.25M.
When is Global Pharmatech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Global Pharmatech overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Global Pharmatech pay dividends?
Global Pharmatech does not currently pay dividends.
What is Global Pharmatech’s EPS estimate?
Global Pharmatech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Global Pharmatech have?
Global Pharmatech has 415,211,800 shares outstanding.
Which hedge fund is a major shareholder of Global Pharmatech?
Currently, no hedge funds are holding shares in GBLP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Global Pharmatech
Global Pharmatech, Inc. engages in the discovery, development, manufacturing, and marketing of proprietary drugs developed based on traditional Chinese medicine. Its operations are based in the People's Republic of China with sales distribution in China, Singapore, Malaysia, Indonesia, and USA. The company was founded on June 26, 2001 and is headquartered in Hong Kong.
Sector
General
Industry
Medical - Pharmaceuticals
CEO
Mei Sheng Liao
Employees
217
Website
www.globalp.com
Address
Fa Yuen Commercial Building, Hong Kong, MA, 02453, HK